Eli Lilly has announced a number of leadership changes, promoting several experienced Lilly leaders to executive roles, effective in 2018.
Following the retirement of CFO Derica Rice, Josh Smiley has been promoted to senior vice president and chief financial officer.
Dan Skovronsky has been promoted to senior vice president for science and technology and president of Lilly Research Labs.
Myles O'Neill has been promoted to senior vice president and president of manufacturing operations.
Aarti Shah, senior vice president and chief information officer, has been named an executive officer and will join Lilly's executive committee.
Chief executive David Ricks said: “This team will help us maintain focus as we work to bring forward new medicines in diabetes, cancer, immunology, neurodegeneration and pain and change the path of serious disease."
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze